KeyBank National Association’s Teva Pharmaceuticals TEVA Stock Holding History

KeyBank National Association’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Buy	20,532 +2,138	+12%	+$71.2K	﹤0.01%	776
2026 Q1	$554K	Buy	18,394 +10,019	+120%	+$322K	﹤0.01%	785
2025 Q4	$261K	Buy	+8,375	New	+$206K	﹤0.01%	1066
2018 Q1	–	Sell	-15,792	Closed	-$299K	–	1089
2017 Q4	$299K	Sell	15,792 -15,391	-49%	-$232K	﹤0.01%	895
2017 Q3	$549K	Sell	31,183 -4,954	-14%	-$111K	﹤0.01%	748
2017 Q2	$1.2M	Sell	36,137 -8,387	-19%	-$260K	0.01%	526
2017 Q1	$1.43M	Sell	44,524 -4,328	-9%	-$148K	0.01%	471
2016 Q4	$1.77M	Sell	48,852 -11,718	-19%	-$468K	0.01%	399
2016 Q3	$2.79M	Sell	60,570 -1,285	-2%	-$67K	0.02%	311
2016 Q2	$3.11M	Sell	61,855 -3,885	-6%	-$207K	0.02%	281
2016 Q1	$3.52M	Sell	65,740 -8,391	-11%	-$492K	0.02%	269
2015 Q4	$4.87M	Sell	74,131 -2,258	-3%	-$140K	0.03%	245
2015 Q3	$4.31M	Sell	76,389 -2,131	-3%	-$138K	0.03%	267
2015 Q2	$4.64M	Sell	78,520 -5,900	-7%	-$364K	0.03%	277
2015 Q1	$5.26M	Sell	84,420 -2,287	-3%	-$133K	0.03%	263
2014 Q4	$4.99M	Sell	86,707 -7,089	-8%	-$395K	0.03%	267
2014 Q3	$5.04M	Sell	93,796 -14,121	-13%	-$748K	0.03%	271
2014 Q2	$5.66M	Sell	107,917 -13,060	-11%	-$668K	0.04%	249
2014 Q1	$6.39M	Sell	120,977 -37,917	-24%	-$1.75M	0.05%	237
2013 Q4	$6.37M	Sell	158,894 -73,529	-32%	-$2.9M	0.04%	236
2013 Q3	$8.78M	Sell	232,423 -83,441	-26%	-$3.25M	0.06%	203
2013 Q2	$12.4M	Buy	+315,864	New	+$12.3M	0.05%	397

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

KeyBank National Association's TEVA Position: Q2 2026 in Review

KeyBank National Association increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $71.2K and bringing the position to 20,532 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

KeyBank National Association first reported a position in TEVA in Q2 2013 and has held it in 22 quarters since. The position peaked at $12.4M in Q2 2013. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

KeyBank National Association held 20,532 shares of Teva Pharmaceuticals worth $696K as of Q2 2026.
KeyBank National Association bought 2,138 Teva Pharmaceuticals shares in Q2 2026, an estimated $71.2K.
Teva Pharmaceuticals made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #776 holding.
KeyBank National Association first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
KeyBank National Association's Teva Pharmaceuticals position peaked at $12.4M in Q2 2013.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.